Press Releases

CRAWLEY, United Kingdom, Sept. 5, 2019 /PRNewswire/ -- Elekta (EKTA-B.ST) has signed a distribution agreement with DOSIsoft, a company that offers patient-specific quality assurance (QA) software,

SHANGHAI and EMERYVILLE, Calif., Sept. 4, 2019 /PRNewswire/ -- Berkeley Lights, Inc. (BLI), a pioneer and leader in digital cell biology

FRISCO, Texas, Sept. 4, 2019 /PRNewswire/ -- Addus HomeCare Corporation (Nasdaq: ADUS) ("Addus" or the "Company"), a provider of comprehensive home care services, today announced the pricing of an underwritten public offering of 2,000,000 shares of common stock ("Common Stock") at the public offering price of $79.50 per share. Addus ha

ATLANTA, Sept. 4, 2019 /PRNewswire/ -- Sickle Cell disease is a condition that affects people around the world. In Georgia, there are more than 7,000 people living with Sickle Cell. "We want to raise awareness about the serious health problems associated with Sickle Cell Disease which is characterized by debilitating pain and life-threatening complications,"&n

PALO ALTO, Calif., Sept. 4, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical-stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today announced that presentations on its research will be made at EURETINA 2019 Congress being held from September 5 &nda

AUSTIN, Texas, Sept. 4, 2019 /PRNewswire/ -- The Hogg Foundation for Mental Health is accepting proposals for the Texas Communities Count initiative, which will

BOSTON, Sept. 4, 2019 /PRNewswire/ -- Ethos today announced that the organization's Board of Directors has appointed Valerie Frias as Chief Executive Officer, succeeding Dale Mitchell, who is retiring after nearly 30 years of service. As CEO, Frias will be responsible for providing vision, leadership, an

LOS ANGELES, Sept. 4, 2019 /PRNewswire/ --If You Purchased PROVIGIL®, NUVIGIL®, or Generic Provigil® (Modafinil) a CALIFORNIA ATTORNEY GENERAL Settlement Could Affect YouINFORMATION ABOUT THE CALIFORNIA

NEWARK, Calif., Sept. 4, 2019 /PRNewswire/ -- Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported that on August 30, 2019, it issued inducement awards to two recently hired employees in accordance with their employment offer letters. The awards were granted under the Protagonist Therapeutics Inducement Award Plan, which was ado

PRINCETON, N.J. and SAN DIEGO, Sept. 4, 2019 /PRNewswire/ -- Adastra Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of proprietary medicines for the treatment of cancer, today announced that Scott Megaffin, Chief Executive Officer, will present at the 2019 Janney Healthca